Kobayashi, Y.; Takeda, T.; Kunitomi, H.; Chiwaki, F.; Komatsu, M.; Nagai, S.; Nogami, Y.; Tsuji, K.; Masuda, K.; Ogiwara, H.;
et al. Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer. Pharmaceuticals 2022, 15, 124.
https://doi.org/10.3390/ph15020124
AMA Style
Kobayashi Y, Takeda T, Kunitomi H, Chiwaki F, Komatsu M, Nagai S, Nogami Y, Tsuji K, Masuda K, Ogiwara H,
et al. Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer. Pharmaceuticals. 2022; 15(2):124.
https://doi.org/10.3390/ph15020124
Chicago/Turabian Style
Kobayashi, Yusuke, Takashi Takeda, Haruko Kunitomi, Fumiko Chiwaki, Masayuki Komatsu, Shimpei Nagai, Yuya Nogami, Kosuke Tsuji, Kenta Masuda, Hideaki Ogiwara,
and et al. 2022. "Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer" Pharmaceuticals 15, no. 2: 124.
https://doi.org/10.3390/ph15020124
APA Style
Kobayashi, Y., Takeda, T., Kunitomi, H., Chiwaki, F., Komatsu, M., Nagai, S., Nogami, Y., Tsuji, K., Masuda, K., Ogiwara, H., Sasaki, H., Banno, K., & Aoki, D.
(2022). Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer. Pharmaceuticals, 15(2), 124.
https://doi.org/10.3390/ph15020124